CTS Corporation (CTS) Q3 2025 Earnings Call Transcript
Sales Sales in the third quarter were $143 million, up 8% from $132 million in the third quarter of 2024. Diversified end market sales increased 22% year-over-year, while transportation sales were down 7% from the same period last year due to softness in commercial vehicle products.
Gross Margin Adjusted gross margin was 38.9% in the third quarter, up 66 basis points compared to the third quarter of 2024. This improvement was attributed to operational execution and minimal impact from tariffs.
Adjusted EBITDA Adjusted EBITDA was 23.8% in the quarter, a reduction of 55 basis points compared to the third quarter of 2024, but an improvement of 86 basis points sequentially. The year-over-year reduction was not explicitly explained.
Adjusted Diluted Earnings Per Share Adjusted diluted earnings were $0.60 per share, down from $0.61 in the third quarter of 2024. The decrease was primarily due to an unfavorable impact from recent U.S. tax legislation.
Operating Cash Flow Operating cash flow in the third quarter was $29 million, down from $35 million in the third quarter of 2024. The reasons for this decline were not explicitly mentioned.
SyQwest Sales SyQwest sales were $8.8 million during the quarter, contributing to the growth in aerospace and defense sales, which were up 23% year-over-year.
Transportation Sales Transportation sales were $58.5 million in the third quarter, down approximately 7% from the same period last year due to softness in commercial vehicle products.
Aerospace and Defense Sales Aerospace and defense sales in the third quarter were up 23% from the third quarter of 2024. This growth was supported by SyQwest revenues and multiple orders for sonar applications.
Industrial Market Sales Sales in the industrial market were up 21% year-over-year and 9% sequentially, driven by a steady recovery with OEMs and distribution customers.
Medical End Market Sales Medical end market sales were up 22% compared to the same period in 2024, with strong demand for minimally invasive applications and therapeutic products.
Trade with 70% Backtested Accuracy
Analyst Views on CTS
About CTS
About the author

- Dividend Declaration: CTS Corporation's Board of Directors has declared a cash dividend of $0.04 per share, scheduled for payment on April 24, 2026, to shareholders of record as of March 27, 2025, demonstrating the company's commitment to shareholder returns.
- Shareholder Return Strategy: This dividend reflects CTS's strong cash flow and profitability, aimed at boosting investor confidence and attracting more long-term investors to the stock.
- Market Positioning: As a leading manufacturer of sensors, actuators, and electronic components, CTS serves multiple markets including aerospace/defense, industrial, medical, and transportation, showcasing its diversified business model and market adaptability.
- Global Operations: With manufacturing capabilities in North America, Europe, and Asia, CTS is well-positioned to meet global customer demands, further solidifying its leadership in technological innovation and market competition.
- Significant Revenue Growth: CTS Corporation reported fourth quarter sales of $137 million, reflecting a 9% year-over-year increase, with diversified market sales growing by 16%, demonstrating the successful implementation of the company's diversification strategy and strong market demand.
- Strong Medical Market Performance: The medical market saw a 41% year-over-year sales increase, highlighting robust growth momentum in therapeutic applications, which further solidifies CTS's market position in the healthcare sector.
- Margin Improvement: The adjusted gross margin for the fourth quarter reached 39.1%, up 150 basis points from the prior year, primarily driven by operational efficiencies and an improved market mix, enhancing the company's profitability.
- Optimistic 2026 Outlook: Management anticipates sales in the range of $550 million to $580 million for 2026, with adjusted EPS expected between $2.30 and $2.45, reflecting confidence in future market demand and ongoing product innovation.
- Strong Earnings Performance: CTS Corporation reported a Q4 non-GAAP EPS of $0.62, beating expectations by $0.02, which reflects the company's ongoing profitability enhancement and bolsters investor confidence.
- Significant Revenue Growth: The company achieved Q4 revenue of $137.27 million, an 8.5% year-over-year increase, surpassing expectations by $1.41 million, indicating CTS's robust performance amid recovering market demand and suggesting future growth potential.
- Margin Improvement: The adjusted gross margin rose to 39.1%, up 150 basis points from 37.6% in Q4 2024, demonstrating positive progress in cost control and pricing strategies, which will help enhance overall profitability.
- Optimistic 2026 Outlook: CTS expects full-year 2026 sales to range between $550 million and $580 million, with adjusted diluted EPS projected at $2.30 to $2.45, both exceeding market consensus, showcasing the company's confidence in future performance and competitive positioning.
- Earnings Release Schedule: CTS Corporation will release its fourth quarter and full-year 2025 earnings on February 10, 2026, at 8:00 a.m. ET, providing investors with crucial financial data and performance insights.
- Conference Call Details: A conference call is scheduled for the same day at 10:00 a.m. ET, where management will discuss the earnings results, and investors can register online to receive dial-in information and conference ID, enhancing engagement with management.
- Live Webcast Availability: The conference call will feature a live audio webcast accessible directly from CTS Corporation's investor website, with the recording archived for one year, ensuring long-term availability of the information.
- Company Background: CTS Corporation is a leading designer and manufacturer of sensors, actuators, and electronic components, serving aerospace/defense, industrial, medical, and transportation markets, showcasing its broad impact and technological strength across multiple industries.

- Conference Presentation: CTS Corporation's CEO Kieran O’Sullivan is scheduled to present at the 28th Annual Needham Growth Conference on January 13, 2026, at the Lotte New York Palace Hotel, highlighting the company's advancements in sensors and electronic components.
- Live Webcast: The presentation will begin at 4:30 PM Eastern Time, allowing investors to access the live stream via the CTS website or the conference site, thereby enhancing interaction and transparency between the company and its investors.
- Replay Availability: Following the presentation, the webcast will be available for replay on the conference website for 90 days, ensuring that investors who cannot attend live can still access critical information, thus improving information accessibility.
- Company Overview: CTS Corporation specializes in designing and manufacturing sensors, actuators, and electronic components, serving various markets including aerospace, industrial, medical, and transportation, showcasing its broad capabilities in technological innovation and market application.
- Conference Presentation: CTS CEO Kieran O'Sullivan will present at the 28th Annual Needham Growth Conference on January 13, 2026, at the Lotte New York Palace Hotel, showcasing the company's advancements in sensors and electronic components.
- Live Webcast: The presentation is scheduled to begin at 4:30 PM Eastern Time, allowing investors to access the event via the CTS website or conference site, enhancing interaction and transparency between the company and its investors.
- Replay Availability: The webcast will be available for replay on the conference website for 90 days post-presentation, ensuring that investors who cannot attend live can still access critical information, thereby increasing the company's information dissemination reach.
- Company Overview: CTS is a leading manufacturer of sensors, actuators, and electronic components serving aerospace, industrial, medical, and transportation markets, demonstrating its extensive influence and technological strength in the global market.






